CD4 and chronic kidney disease: Additionally, the highest CKD incidence rate (7/100 person-years, 95% CI 5–8) was found among patients treated with the INSTI-based regimen and the CD4/CD8 ratio was unrecovered, and was significantly higher than the CD4/CD8 ratio recovery patients (Supplementary Table 4).